| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Glycosaminoglycan degradation 0.9752747252747253 2.6105128144250904 0.0090406584793441 0.9956996718000614 0.9615118185155164 6 P16278,P54802,P07686,P06865,P15586 5 |
| Degradation pathway of sphingolipids including diseases 0.9308718529418156 2.486834517493732 0.0128885335217978 0.9995834011452378 0.9615118185155164 7 P16278,P17900,P06280,P06865 4 |
| Sphingolipid metabolism in senescence 0.8225311192102596 2.247370068602457 0.0246163862455428 0.9999996799092272 0.9615118185155164 11 P16278,Q06136,P24941,P11802,Q13510,P04062 6 |
| Ebola virus infection in host 0.5483048970712544 2.1468993166130663 0.0318012980442277 0.99999999620949 0.9615118185155164 37 P07858,P04439,O15118,P10321,P41440,P61916,P01889 7 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.5843217693673023 2.13826731554239 0.0324950536828827 0.9999999975344354 0.9615118185155164 25 Q15125,P14324,Q15392,P48449 4 |
| H19 action rbe2f1 signaling and cdkbetacatenin activity 0.8360022396956879 2.073846790931783 0.0380935420063515 0.999999999924194 0.9615118185155164 6 P11802,Q16527 2 |
| Metabolic pathway of ldl hdl and tg including diseases 0.8995902403375524 2.05173815657306 0.0401951163926137 0.9999999999795932 0.9615118185155164 4 Q8WTV0 1 |
| 3q29 copy number variation syndrome 0.7888631644815088 2.0488105742151577 0.0404806413758707 0.9999999999829297 0.9615118185155164 10 Q8NCM8,P02786,P61088 3 |
| Statin inhibition of cholesterol production 0.8456107799968735 1.9517136128686203 0.050972215498886 0.9999999999999768 1.0 5 Q8WTV0 1 |
| 7oxoc and 7betahc pathways 0.768343738940461 1.9139868622606064 0.0556218344385586 0.9999999999999988 1.0 9 Q15125,P61916 2 |
| Inclusion body myositis 0.9424290078004836 1.8944264947203535 0.0581684224473111 0.9999999999999998 1.0 3 P05067 1 |
| Sarscov2 and covid19 pathway 0.8497971892818107 1.8617884935148885 0.0626329090368456 1.0 1.0 4 Q8WTV0 1 |
| Cholesterol biosynthesis with skeletal dysplasias 0.763864342747132 1.8162332818274456 0.0693345947413961 1.0 1.0 7 Q15125,Q15392 2 |
| Ferroptosis 0.5630261972150166 1.757209451226129 0.0788821148997716 1.0 1.0 22 P02786,Q15758,P09601,P08195,P32929 5 |
| Tolllike receptor signaling related to myd88 0.9034291904302372 1.752124880460724 0.0797523368969415 1.0 1.0 3 Q9Y6K9 1 |
| Bile acids synthesis and enterohepatic circulation 0.8957578510499109 1.723961351807371 0.0847148204067154 1.0 1.0 3 P01130 1 |
| Ketogenesis and ketolysis 0.7369769881788705 1.671848682412589 0.0945541642881908 1.0 1.0 6 O43772 1 |
| Oxidative phosphorylation 0.5011336098489003 1.653903572823633 0.0981471066093035 1.0 1.0 31 Q15904,O96000,O43674,P56385,O95169,O75787 6 |
| Metabolism of spingolipids in er and golgi apparatus 0.8764241118083633 1.6527565673354934 0.0983804167125637 1.0 1.0 3 Q10472 1 |
| Ebsteinbarr virus lmp1 signaling 0.7866610350109469 1.616401039905873 0.1060076336844364 1.0 1.0 4 Q9Y6K9 1 |
| Proteoglycan biosynthesis 0.7866525551660517 1.616367786606273 0.1060148188126213 1.0 1.0 4 Q8WVQ1 1 |
| Proteasome degradation 0.4640074252060496 1.6115902927797443 0.1070511244408973 1.0 1.0 41 P49721,P28070,P04439,P10321,P28072,O00231,P01889 7 |
| Apoptosisrelated network due to altered notch3 in ovarian cancer 0.6397844866373193 1.56794298181478 0.1168944396331004 1.0 1.0 14 P05067 1 |
| Vitamin d metabolism 0.8499542543458412 1.5548073244725256 0.1199919642050999 1.0 1.0 3 P38435,P04062 2 |
| Microglia pathogen phagocytosis pathway 0.7596095179987828 1.5099880317113143 0.1310464781045959 1.0 1.0 4 O15143,O00443,P07948 3 |
| Sphingolipid metabolism overview 0.6793931810362644 1.490596198600317 0.1360675429632853 1.0 1.0 8 P27544,Q13510,Q06136 3 |
| Sphingolipid metabolism integrated pathway 0.6793931810362644 1.490596198600317 0.1360675429632853 1.0 1.0 8 P27544,Q13510,Q06136 3 |
| Vitamin b12 metabolism 0.674441603645476 1.469021619832769 0.1418269252740047 1.0 1.0 8 Q8WTV0 1 |
| Proximal tubule transport 0.6664097412465214 1.4677594929971505 0.1421695640814186 1.0 1.0 9 P08183,P08195,P05026,P11166 4 |
| Sphingolipid pathway 0.6522621349062664 1.4047136315544897 0.1601064505979075 1.0 1.0 9 Q13510,Q06136,P04062 3 |
| Metapathway biotransformation phase i and ii 0.53198717284059 1.3850611742390029 0.1660337625690784 1.0 1.0 20 Q7LGA3,Q86UY6 2 |
| Allograft rejection 0.6224564750020969 1.34267317755599 0.1793778235959868 1.0 1.0 11 P04439,P10321,P01889 3 |
| Kennedy pathway from sphingolipids 0.6918797449651454 1.339091618056892 0.1805408488540349 1.0 1.0 5 P35790,P48651 2 |
| Antiviral and antiinflammatory effects of nrf2 on sarscov2 pathway 0.6917753259444609 1.3386680500276866 0.1806787618724561 1.0 1.0 5 P09601 1 |
| Type ii interferon signaling ifng 0.6883089141661445 1.3246043308781492 0.1853024187280945 1.0 1.0 5 P01889 1 |
| Nucleotidebinding oligomerization domain nod pathway 0.6401929005122333 1.3191784575038903 0.1871094584837069 1.0 1.0 8 Q9P0J0,Q7L5N1,Q13685,Q9Y6K9 4 |
| Mbdnf and probdnf regulation of gaba neurotransmission 0.6461068702289934 1.316486978746994 0.1880106460201789 1.0 1.0 7 O94973,O95782,Q13464,P61586,P19174,P40763 6 |
| Resistin as a regulator of inflammation 0.6843025145459102 1.3083443619146706 0.1907565347996809 1.0 1.0 5 P19174,Q9Y6K9 2 |
| Vitamin d in inflammatory diseases 0.699373467461859 1.2713764515791373 0.2035947559809834 1.0 1.0 4 Q9Y6K9 1 |
| Mrna protein and metabolite inducation pathway by cyclosporin a 0.7676779331143695 1.2484163683617509 0.2118786177897682 1.0 1.0 3 P08195 1 |
| Network map of sarscov2 signaling pathway 0.4468875112433436 1.2436311338251524 0.2136353521688163 1.0 1.0 30 P07858,Q08380,Q07021,Q9Y6K9 4 |
| Signal transduction through il1r 0.6856609459876121 1.2169432171680832 0.2236258210307578 1.0 1.0 4 Q9H0E2,Q16539 2 |
| Mechanoregulation and pathology of yaptaz via hippo and nonhippo mechanisms 0.6204823565823794 1.2060699172303564 0.2277905329557128 1.0 1.0 7 Q9Y6E0 1 |
| Il10 antiinflammatory signaling pathway 0.6414403417760418 1.1342981018075853 0.2566695251379496 1.0 1.0 5 P09601,P30043,P53004,P40763 4 |
| Familial hyperlipidemia type 3 0.9746951219512232 1.1009769585449298 0.2709066855081778 1.0 1.0 2 Q8WTV0 1 |
| Folate metabolism 0.5277747631428814 1.1009526801771536 0.2709172524731174 1.0 1.0 16 Q8WTV0,P01130,P41440 3 |
| Oxysterols derived from cholesterol 0.5960711369692874 1.1008534397437293 0.2709604490131401 1.0 1.0 7 Q15125,Q9UBM7 2 |
| Il17 signaling pathway 0.6554395367101694 1.097200396814089 0.2725537997476417 1.0 1.0 4 Q9Y6K9 1 |
| Leukocyteintrinsic hippo pathway functions 0.5924018099109191 1.0850569948519588 0.2778964128412116 1.0 1.0 7 Q9Y6E0,P63000,Q16539 3 |
| Nanomaterial induced apoptosis 0.6287120373746111 1.0827146625686292 0.2789350937776014 1.0 1.0 5 O95831,Q9NR28 2 |
| T cell receptor and costimulatory signaling 0.6517045029549008 1.0824434175394704 0.2790555447181804 1.0 1.0 4 P19174 1 |
| Mitochondrial complex iv assembly 0.563533615863144 1.0355614328750586 0.3004067924095985 1.0 1.0 10 P14406 1 |
| Map3k1 role in promoting and blocking gonadal determination 0.6134737433978025 1.021132558876838 0.3071916391963074 1.0 1.0 5 P49841,Q13464 2 |
| Nrf2 pathway 0.4338325577645339 1.0174071702325909 0.3089597724336728 1.0 1.0 23 Q9H2J7,P25685,P09601,P11166,Q13501 5 |
| Cellular proteostasis 0.6341841816075966 1.0134189020396347 0.3108601145872551 1.0 1.0 4 Q9NQP4 1 |
| Tlr4 signaling and tolerance 0.6286454797473855 0.991680882774556 0.3213532195543056 1.0 1.0 4 Q9Y6K9 1 |
| Interleukin1 induced activation of nfkb 0.939939024390244 0.9851693447309164 0.3245408957654461 1.0 1.0 2 Q13501 1 |
| Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells 0.5686044400137751 0.9828868144513108 0.325663148021694 1.0 1.0 7 P51148,O14964 2 |
| Mirnas involvement in the immune response in sepsis 0.695332581977648 0.9806346606054296 0.3267729355599273 1.0 1.0 3 Q9Y6K9 1 |
| Il1 signaling pathway 0.53786879007647 0.9803594989185224 0.3269086944252333 1.0 1.0 12 Q13501,Q9H0E2,Q9Y6K9 3 |
| Selenium micronutrient network 0.5368643253951968 0.9755915382238782 0.3292669194662037 1.0 1.0 12 Q8WTV0 1 |
| Praderwilli and angelman syndrome 0.5557096544980051 0.9487346363946846 0.3427555932135719 1.0 1.0 8 P06400,P11802 2 |
| Angiogenesis 0.6837868513381316 0.9385069090773313 0.3479839680184911 1.0 1.0 3 P19174 1 |
| Cardiac progenitor differentiation 0.6745959133882229 0.9051610071525136 0.3653800959241551 1.0 1.0 3 P49841,Q16539 2 |
| Cannabinoid receptor signaling 0.581743404153741 0.8939217064012687 0.3713637830157594 1.0 1.0 5 Q8NCG7,P10644 2 |
| Mirna biogenesis 0.6006711409396022 0.8827287907393345 0.3773828226711371 1.0 1.0 4 P62826,Q9UPY3,Q15633 3 |
| Id signaling pathway 0.8881097560975675 0.8168988257937443 0.4139862488900925 1.0 1.0 2 P24941 1 |
| Nrp1triggered signaling pathways in pancreatic cancer 0.5148344172497492 0.8156899991860487 0.414677460328162 1.0 1.0 10 O14786 1 |
| Genes controlling nephrogenesis 0.5201613788905781 0.7779458478496071 0.4366009380863769 1.0 1.0 7 O94813 1 |
| Small cell lung cancer 0.5003138885909806 0.7758798296322517 0.4378199431272045 1.0 1.0 11 P24941,P11802,Q9Y6K9,P05556 4 |
| Rac1pak1p38mmp2 pathway 0.4834453570713822 0.7553216527203569 0.4500560098216875 1.0 1.0 13 P16949,Q9Y6K9 2 |
| Development of ureteric collection system 0.5451818372750715 0.7502347276131579 0.4531133466567785 1.0 1.0 5 O94813 1 |
| Vitamin d receptor pathway 0.4797860526363393 0.7093470767122945 0.4781091211756378 1.0 1.0 12 P24941,P08183,Q92604,P09493,P20020,Q96KA5 6 |
| Spinal cord injury 0.4154627852822225 0.6981921257096766 0.4850570502499627 1.0 1.0 20 P24941,O94813,Q08722,P11802 4 |
| Synaptic signaling pathways associated with autism spectrum disorder 0.4924411873233816 0.6965512065199351 0.4860837007235878 1.0 1.0 9 Q8N122,P54619,P49841,P21359,Q13131 5 |
| Pancreatic adenocarcinoma pathway 0.4131247738024322 0.6849791621304051 0.4933570703613621 1.0 1.0 20 P11802,P11233,Q9Y6K9 3 |
| Wnt signaling 0.4542232918422456 0.6815395574489841 0.4955301454473706 1.0 1.0 15 Q13557,P67870,P49841,P63000,P68400,Q8TAA9,Q9HCK8 7 |
| Glycogen synthesis and degradation 0.4366244211727412 0.6696515216693563 0.5030799620933761 1.0 1.0 17 P30154,P49841,P11216,P13807,P36871,P49840,Q16851,P0DP25,Q14738 9 |
| Tgfbeta signaling pathway 0.36288818866981 0.6622305719813762 0.5078234640423163 1.0 1.0 33 Q13573,P05067,O14964,P05556 4 |
| Apoptosis modulation by hsp70 0.5177190304505894 0.6455247896745376 0.518587158914346 1.0 1.0 5 O95831 1 |
| Tcell antigen receptor tcr pathway during staphylococcus aureus infection 0.4729288111289419 0.6328819091571745 0.526810762449542 1.0 1.0 10 P11802,P19174,Q9Y6K9 3 |
| Ranklrank signaling pathway 0.4415862586117582 0.6206464159646352 0.5348322927025513 1.0 1.0 15 Q16539,P63000,O95340,Q9Y6K9,P07948,P19174,Q13501 7 |
| Glycerophospholipid biosynthetic pathway 0.4686517020182967 0.597070391193067 0.5504603851337713 1.0 1.0 9 Q8WUK0,O14735,P48651 3 |
| Neuroinflammation 0.5199361762355604 0.5824302958678709 0.5602768798870614 1.0 1.0 4 Q8N9N2 1 |
| Familial hyperlipidemia type 2 0.8100609756097858 0.5797005463362778 0.5621165748708932 1.0 1.0 2 P01130 1 |
| Wnt signaling pathway and pluripotency 0.4419071725562323 0.564830977639811 0.5721887346032783 1.0 1.0 13 P30154,P01130 2 |
| P53 transcriptional gene network 0.4591428127927177 0.5583126280865298 0.5766309232716018 1.0 1.0 9 P04066 1 |
| Ras signaling 0.3490409730819993 0.5458312728563055 0.5851819243788903 1.0 1.0 29 P51148,Q9UQ13,P63218,Q9UJF2,Q9Y6K9,P20339,P0DP25,P11233,P19174 9 |
| Electron transport chain oxphos system in mitochondria 0.3126325850184674 0.5236837794873936 0.6004984993275961 1.0 1.0 48 O75964,O96000,O43674,O75880,O43676,P13073,P56385,P14406,O95169 9 |
| Sterol regulatory elementbinding proteins srebp signaling 0.3391840557499477 0.5052096222980835 0.6134116126689066 1.0 1.0 34 Q8WTV0,P01130,P48449 3 |
| Sudden infant death syndrome sids susceptibility pathways 0.3404976669164766 0.4890617504087177 0.6247979800027843 1.0 1.0 25 P42892 1 |
| Monoamine transport 0.7737804878049027 0.4791968371525446 0.6317986041060033 1.0 1.0 2 O15127 1 |
| Tyrobp causal network in microglia 0.4714933225818388 0.4788522483435278 0.6320437438019402 1.0 1.0 5 P61916 1 |
| Immune response to tuberculosis 0.5443338694079711 0.4662247621792886 0.6410546266051782 1.0 1.0 3 O75925 1 |
| Calcium regulation in cardiac cells 0.3338574178538616 0.4488542350312924 0.6535368117405806 1.0 1.0 29 P10644,P20020,P63218,P31946,P54709,P16615,P0DP25,P05026 8 |
| Cell migration and invasion through p75ntr 0.4567683979157628 0.429116161776942 0.6678386912597034 1.0 1.0 5 P61586,P63000 2 |
| Gammaglutamyl cycle for the biosynthesis and degradation of glutathione including diseases 0.5317388580735716 0.4290307075484364 0.667900877734831 1.0 1.0 3 P48637 1 |
| Orexin receptor pathway 0.3922603011010162 0.4225603324847896 0.6726160732566364 1.0 1.0 16 P01130,P11166 2 |
| Head and neck squamous cell carcinoma 0.3914970963002765 0.4191805257985717 0.6750842033360729 1.0 1.0 16 Q8N122,P06400,P11802,P62753,Q13131,Q14145 6 |
| Hepatitis b infection 0.3534952280857676 0.4090428194269442 0.6825082377968896 1.0 1.0 21 Q15904 1 |
| Tgfbeta signaling in thyroid cells for epithelialmesenchymal transition 0.5204563899217001 0.3968322774139732 0.6914911469383029 1.0 1.0 3 P19022 1 |
| Endoplasmic reticulum stress response in coronavirus infection 0.4116296970188248 0.3673922888068582 0.7133264226947469 1.0 1.0 8 Q12972,Q15435 2 |
| Osteoblast differentiation and related diseases 0.4103644086718475 0.3629995129873591 0.7166052481322507 1.0 1.0 8 P78527,O00443 2 |
| Melanoma 0.382759431778058 0.3578483096855111 0.7204568353421612 1.0 1.0 15 P11802,P0DP25 2 |
| Tcell activation sarscov2 0.3960638939600875 0.3560332195214092 0.721815687465674 1.0 1.0 12 Q8N122,P49841,P19174,Q9Y6K9 4 |
| Glycosylation and related congenital defects 0.3980509581780456 0.3496897932739764 0.7265715144425111 1.0 1.0 11 O75340,Q9BV10,Q9Y5P6 3 |
| Aryl hydrocarbon receptor pathway wp2873 0.4441732763880496 0.3380760007658328 0.7353059154696808 1.0 1.0 4 Q15185,Q16543,O00170 3 |
| Methionine metabolism leading to sulfur amino acids and related disorders 0.427718140267029 0.337081818211776 0.7360552231569506 1.0 1.0 5 P32929 1 |
| Tolllike receptor signaling pathway 0.3876092209717569 0.3122510838108205 0.7548497121715381 1.0 1.0 11 Q9Y6K9 1 |
| Bladder cancer 0.3961738489534701 0.3094942163475328 0.7569456110432828 1.0 1.0 7 P11802 1 |
| Apoptosis modulation and signaling 0.374271843483525 0.3054806812311542 0.7600000813813483 1.0 1.0 14 O95831,Q9H0E2,Q9NR28 3 |
| Regulatory circuits of the stat3 signaling pathway 0.3930441709437903 0.3048533665857151 0.760477834168904 1.0 1.0 8 Q8N122,P16949 2 |
| Angiopoietinlike protein 8 regulatory pathway 0.3090686546356129 0.3025522229298319 0.762231129378621 1.0 1.0 28 Q8N122,P54619,P49841,Q15642,P41440,Q9UPT5,O00443,O75955,Q13131,P11166 10 |
| Glial cell differentiation 0.697865853658549 0.2972340780078538 0.7662878063872982 1.0 1.0 2 P26038 1 |
| Onecarbon metabolism and related pathways 0.3711622422355572 0.293852839405155 0.7688703565282247 1.0 1.0 14 O43865,P35790,P32929 3 |
| Camkk2 pathway 0.3777999384370212 0.2895638873439267 0.7721498975814556 1.0 1.0 12 P09601 1 |
| Pentose phosphate pathway in senescent cells 0.4092157461092287 0.2833347692560427 0.7769202267866324 1.0 1.0 5 P11413,P37837,P29401,O95336 4 |
| Hippo signaling regulation pathways 0.3626169525704834 0.2788277995156636 0.7803769792482729 1.0 1.0 15 P19022,P54619,P10644,P60953,P63000,Q9Y6E0,Q13131 7 |
| Oligodendrocyte specification and differentiation leading to myelin components for cns 0.6878048780487802 0.2765143361709802 0.7821530500608631 1.0 1.0 2 P09543 1 |
| Brainderived neurotrophic factor bdnf signaling pathway 0.2920008766755714 0.2763157843882405 0.7823055334916238 1.0 1.0 43 Q96P70,P49841,O00763,Q16539,Q7L576,P63000,P20042,Q99523,P67809,Q9Y6K9,P68400,Q13131,P19174,Q13501 14 |
| Mitochondrial complex i assembly model oxphos system 0.301303484830054 0.2599031022946863 0.7949385182047983 1.0 1.0 29 P51970,O96000,O43674,Q9P0J0,O43676,O95169 6 |
| Complement system 0.3759884175831588 0.2568003119043877 0.7973329292805478 1.0 1.0 9 Q07021 1 |
| Glycolysis in senescence 0.368653139952351 0.2484387181941964 0.8037949796010775 1.0 1.0 11 P11413,P06400 2 |
| Cholesterol biosynthesis pathway 0.3570104848384448 0.2430735019857365 0.8079484580459366 1.0 1.0 14 P14324,Q9UBM7,P48449 3 |
| Ethanol effects on histone modifications 0.3668084531264743 0.2425358534394423 0.8083649789571243 1.0 1.0 11 Q9H9T3,P41440 2 |
| Nuclear receptors metapathway 0.2721888318814423 0.2306710381547329 0.8175703749819645 1.0 1.0 49 Q9H2J7,P08183,P25685,P11802,P09601,P11166,Q13501 7 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.3533604252590237 0.2305733482038642 0.8176462747816888 1.0 1.0 14 O75844,P49841,P55209,O60725,P06400,P11802 6 |
| Aryl hydrocarbon receptor pathway wp2586 0.3664013281493107 0.2277850235182453 0.8198133701591477 1.0 1.0 9 P24941 1 |
| Pi3kaktmtor signaling pathway and therapeutic opportunities 0.3998363819800091 0.2228217060384477 0.8236742736992158 1.0 1.0 4 Q8N122 1 |
| Vasopressinregulated water reabsorption 0.3358180146845591 0.2156827707182889 0.8292350321129787 1.0 1.0 17 P51148,Q15907,Q14204,Q8NCM8,P20339,Q96FJ2 6 |
| Myometrial relaxation and contraction pathways 0.3032887385718695 0.2066914439661342 0.8362508398446022 1.0 1.0 22 P10644,P63218,P31946,P16615,P0DP25,P19174 6 |
| Glioblastoma signaling pathways 0.3290027435617858 0.1914995360676226 0.8481342439776554 1.0 1.0 17 P24941,P11802,P06400,O00443 4 |
| Ncrnas involved in wnt signaling in hepatocellular carcinoma 0.3495480842234764 0.1901460090774731 0.8491947176610266 1.0 1.0 11 P68400,P67870,Q9HCK8 3 |
| Airway smooth muscle cell contraction 0.3719482457983628 0.1885615129194084 0.8504364998519949 1.0 1.0 5 Q13464 1 |
| Target of rapamycin tor signaling 0.347150301103848 0.1740526550823061 0.8618240809412636 1.0 1.0 9 Q13131,Q8N122,P54619,P63000 4 |
| Modulators of tcr signaling and t cell activation 0.3419712910175547 0.168843574644659 0.8659196827266022 1.0 1.0 11 O96000 1 |
| Fragile x syndrome 0.2660480321303092 0.1600587988383333 0.872834756430803 1.0 1.0 47 P05067 1 |
| Nonalcoholic fatty liver disease 0.2613020413331908 0.1576411616804676 0.8747395667506686 1.0 1.0 49 O96000,O43674,Q9P0J0,O43676,P13073,P14406,O95169 7 |
| Cytoplasmic ribosomal proteins 0.3060501895602065 0.1551384600722729 0.8767121624670247 1.0 1.0 75 P62899,P62847,P62277,P46779,P83731,P15880,P39019,P46777,P62753,P23396,P62917,P62241,P62269,P39023,P61353,P46783,P42766,P62857,P62081,P62913,P05387,Q02543,P49207,P62841,P62244,P62266,P46781,P62750,P61254,P27635,P62280,P61513,P62424 33 |
| Apoptosis 0.3306662255468494 0.1505207147322287 0.8803538089234302 1.0 1.0 13 Q9NR28,P55212,Q9Y6K9 3 |
| Eukaryotic transcription initiation 0.320798940536061 0.1505025286989681 0.8803681558489451 1.0 1.0 16 P29083,Q00403,O15160,P29084 4 |
| Metastatic brain tumor 0.4089661482159183 0.1497100638774896 0.8809933678457746 1.0 1.0 3 P60953,Q00534 2 |
| Extracellular vesicles in the crosstalk of cardiac cells 0.6115853658536583 0.1489804658002994 0.8815690469673854 1.0 1.0 2 P40763 1 |
| Vitamin dsensitive calcium signaling in depression 0.3366038062212501 0.1456016276922758 0.884235882967757 1.0 1.0 8 Q8NB78,P20020 2 |
| Cardiac hypertrophic response 0.3296508519473734 0.1413483432060167 0.8875947605932515 1.0 1.0 12 Q9Y6K9,P63000,P49841,Q16539 4 |
| 16p112 distal deletion syndrome 0.3348620778298201 0.140956927102864 0.8879039697109952 1.0 1.0 7 P20338 1 |
| G13 signaling pathway 0.3199551632179447 0.1372533382731503 0.890830551951767 1.0 1.0 15 P60953,Q13464,O14578,P63000,Q7L576 5 |
| Exrna mechanism of action and biogenesis 0.6003048780487801 0.1346293536285761 0.8929049320478022 1.0 1.0 2 Q9UPY3 1 |
| Methylation pathways 0.3985971332723408 0.1341876133460828 0.8932542204444405 1.0 1.0 3 P21964,Q9NZL9 2 |
| Neural crest differentiation 0.3310380449067189 0.1327461144479267 0.8943941715072914 1.0 1.0 8 P49841,P05556 2 |
| Tca cycle nutrient use and invasiveness of ovarian cancer 0.5978658536585364 0.1316779737733898 0.8952390081757602 1.0 1.0 2 P40763 1 |
| Physiological and pathological hypertrophy of the heart 0.327416072514012 0.1246750820748986 0.900780785078812 1.0 1.0 8 P61586,Q13557,P63000,Q16539 4 |
| Interferon type i signaling pathways 0.3110604725127749 0.1218294787350299 0.9030340671871028 1.0 1.0 16 Q8N122,O75925,Q16539,Q53EL6,P63000 5 |
| Mammary gland development pathway pregnancy and lactation stage 3 of 4 0.3456375838926243 0.1180209270952169 0.9060510763412362 1.0 1.0 4 P06753,P61201,P18031 3 |
| Hereditary leiomyomatosis and renal cell carcinoma pathway 0.319537538066409 0.1158911262237709 0.907738828555025 1.0 1.0 12 P54619,O00763,P62753,Q13131,Q14145,P11166 6 |
| Factors and pathways affecting insulinlike growth factor igf1akt signaling 0.3225876506150175 0.1142801399621007 0.9090157253628576 1.0 1.0 8 Q8N122,P05556 2 |
| Glycerolipids and glycerophospholipids 0.3199388958820729 0.109157356135908 0.9130776830061758 1.0 1.0 7 O14735,P48651 2 |
| Joubert syndrome 0.3076706667012173 0.097339848463107 0.9224565117378069 1.0 1.0 14 P41208 1 |
| Microtubule cytoskeleton regulation 0.294542280474113 0.0969774329595238 0.9227443158534652 1.0 1.0 18 Q15691,P06493,P49841,P60953,P16949,Q7KZI7,P63000,Q13464 8 |
| Mirna regulation of prostate cancer signaling pathways 0.3108623573755297 0.0906276401943289 0.9277884686036176 1.0 1.0 9 Q9Y6K9 1 |
| Transsulfuration pathway 0.3084691847344725 0.086294424189576 0.9312323707955432 1.0 1.0 8 P26358 1 |
| Measles virus infection 0.2710069268223525 0.0852977132534826 0.932024709468497 1.0 1.0 22 P68400,P24941,P11802,Q9Y6K9,P26038 5 |
| Omega3 omega6 fatty acid synthesis 0.3061660561660583 0.0850907306272212 0.9321892594686793 1.0 1.0 6 O60488,P33121,O95864,O15254,O95573 5 |
| Transsulfuration and onecarbon metabolism 0.2847906988330322 0.0815409969314091 0.9350117225725328 1.0 1.0 19 P26358,O43865,P32929 3 |
| Pathogenic escherichia coli infection 0.2733169064505433 0.0757295921801134 0.939634232432764 1.0 1.0 21 Q16625,P05556,Q13464,O15143 4 |
| G1 to s cell cycle control 0.2581594519231325 0.0752356647606291 0.9400272083795622 1.0 1.0 26 P24941,P11802,P06400,Q9Y619 4 |
| Intraflagellar transport proteins binding to dynein 0.2998372949413723 0.0709582028009092 0.9434310209302772 1.0 1.0 8 Q8NCM8,Q96FJ2 2 |
| Oncostatin m signaling pathway 0.2957691398689487 0.0702185216230012 0.9440197325883556 1.0 1.0 14 P01130 1 |
| Pentose phosphate metabolism 0.3036313701556213 0.0680460861508749 0.9457489478325424 1.0 1.0 5 P11413,P37837,P29401,O95336 4 |
| Nad metabolism in oncogeneinduced senescence and mitochondrial dysfunctionassociated senescence 0.2904994320628719 0.0633658271347038 0.9494751985403416 1.0 1.0 15 P11413,P06400,P11166,Q8IXJ6 4 |
| Dna damage response only atm dependent 0.2844563287602489 0.0617830049796774 0.9507356376908596 1.0 1.0 17 P49841,P60953,O00443,P01130,P63000 5 |
| Hippomerlin signaling dysregulation 0.2832361309370796 0.0589576014713779 0.9529858784586214 1.0 1.0 17 Q9Y6E0,P05556 2 |
| Neural crest cell migration during development 0.2848834420104802 0.0497073331816121 0.9603556126516352 1.0 1.0 7 P61586,P63000,Q13177 3 |
| Vitamin b12 disorders 0.3059796008575375 0.0496755909670943 0.9603809080250454 1.0 1.0 3 Q99707 1 |
| Liver x receptor pathway 0.4774390243902435 0.0446105129786231 0.96441776285849 1.0 1.0 2 O00767 1 |
| Insulin signaling in adipocytes diabetic condition 0.2760829774252649 0.0433802086646819 0.9653984540455648 1.0 1.0 4 P62753,P31751,O60343 3 |
| Insulin signaling in adipocytes normal condition 0.2760829774252649 0.0433802086646819 0.9653984540455648 1.0 1.0 4 P62753,P31751,O60343 3 |
| Glucuronidation 0.2752459779133784 0.0399730823482771 0.9681145863097396 1.0 1.0 6 P36871,Q96G03,Q16851 3 |
| Cell differentiation expanded index 0.4560975609756092 0.0385000753512863 0.9692889714082048 1.0 1.0 2 P40763 1 |
| Congenital generalized lipodystrophy cgl 0.4326219512195117 0.0337915992069678 0.973043334983154 1.0 1.0 2 P62993 1 |
| Mammary gland development pathway involution stage 4 of 4 0.4088414634146336 0.0306606566625704 0.9755401678345426 1.0 1.0 2 P40763 1 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.2735763870240011 0.0286259728052125 0.9771628972666416 1.0 1.0 10 P20338 1 |
| Sulfation biotransformation reaction 0.2455174770353499 0.0280548154770576 0.9776184318999545 1.0 1.0 4 P11413 1 |
| Micrornas in cardiomyocyte hypertrophy 0.258701527346615 0.0265177807090778 0.9788443516307512 1.0 1.0 20 Q13557,P49841,Q16539,P61586,P63000,Q9Y6K9,Q13464 7 |
| Follicle stimulating hormone fsh signaling pathway 0.2557216966737739 0.02385031094206 0.9809720091180107 1.0 1.0 5 P42345,P62753,P28482,Q16539 4 |
| Cysteine and methionine catabolism 0.2615177784446516 0.0215893257475346 0.9827755483681988 1.0 1.0 7 P48637,P32929 2 |
| Pi3kakt signaling pathway 0.2459128240546537 0.0140241387520735 0.9888107229902788 1.0 1.0 38 P30154,P62879,Q8N122,P49841,P24941,P05556,P11802,P63218,Q13131,P63000,P62753,Q9Y6K9 12 |
| Lncrna in canonical wnt signaling and colorectal cancer 0.2610985385120756 0.0101559322910253 0.9918968777213416 1.0 1.0 15 P68400,P67870,Q9HCK8 3 |
|
|
